Following the pilot study conducted between UConn and Yale (UG3), the National Institutes of Health (NIH) voted to continue the longitudinal aspect of the study during Phase 2 (UH3).
Following the pilot study conducted between UConn and Yale (UG3), the National Institutes of Health (NIH) voted to continue the longitudinal aspect of the study during Phase 2 (UH3).